SB Management’s GeneDx Holdings Warrant WGSWW Stock Holding History

SB Management’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,500,000	Closed	-$37.2M	–	41
2021 Q1	$37.2M	Buy	+2,500,000	New	+$13.9M	0.24%	16

Other funds holding WGSWW

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

SB Management's WGSWW Position: Q2 2021 in Review

SB Management sold out of GeneDx Holdings Warrant (WGSWW) in Q2 2021, closing a stake of 2,500,000 shares — an estimated $37.2M sold.

SB Management first reported a position in WGSWW in Q1 2021 and held it in 1 quarter. The position peaked at $37.2M in Q1 2021. 25 funds tracked by Wall St. Rank hold WGSWW as of Q2 2021.

SB Management reported no remaining GeneDx Holdings Warrant position as of Q2 2021 after selling out during the quarter.
SB Management sold 2,500,000 GeneDx Holdings Warrant shares in Q2 2021, an estimated $37.2M.
SB Management first reported a position in GeneDx Holdings Warrant in Q1 2021 and held it in 1 quarter.
SB Management's GeneDx Holdings Warrant position peaked at $37.2M in Q1 2021.
25 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q2 2021.

Based on SB Management's 13F filing for Q2 2021, filed 16 Aug 2021.